Actively Recruiting
Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
Led by University of Rochester · Updated on 2025-09-17
400
Participants Needed
1
Research Sites
1200 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is being performed to develop assays to determine the impact of the therapy patients receive for treatment of AML or MDS and to determine if these tests can identify those patients who are at a greater risk for having their disease relapse.
CONDITIONS
Official Title
Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Being evaluated for diagnosis and/or treatment of Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome with more than 10 percent blasts in bone marrow
- No cytotoxic therapy for AML or High Grade MDS in past 3 months except hydroxyurea or Revlimid
- No prior allogeneic peripheral blood or bone marrow stem cell transplant for the disease
- Able to sign informed consent before any specimen or clinical data collection
- At least 18 years of age
- No serious medical or psychiatric illness limiting therapy or consent ability
- Informed of investigational nature and provided written informed consent as per guidelines
You will not qualify if you...
- Under 18 years of age
- Limited decision-making capacity
- Received cytotoxic therapy other than hydroxyurea or Revlimid within past 3 months
- Diagnosed with chronic myelogenous leukemia in blast crisis, Acute Promyelocytic Leukemia, or Bi-lineage leukemia
- Previously undergone allogeneic peripheral blood stem cell transplant
- Active malignancy other than AML or MDS or history of treatment for other malignancy within past 2 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Rochester Medical Center
Rochester, New York, United States, 14642
Actively Recruiting
Research Team
M
Michael W Becker, MD
CONTACT
J
Jamie Littleton, MSN,RN,CCRC
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here